Emtricitabine | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Emtricitabine
Annual Reports

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Emtricitabine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 16 USDMF, 2 JDMF, 15 EU WC, 5 KDMF, 20 NDC API, 17 Listed Suppliers, $ API Reference Price

39 API Suppliers
16 USDMF
2 JDMF
15 EU WC
5 KDMF
20 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

259 Drugs in Development

259 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

174 FDF Dossiers, 56 FDA Orange Book, 32 Europe, 24 Canada, 50 South Africa, 12 Listed Dossiers

174 FDF Dossiers
56 FDA Orange Book
32 Europe
24 Canada
50 South Africa
12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE, CAPSULE;ORAL - 200MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG
TABLET;ORAL - 150MG;150MG;200MG;300MG
TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE
TABLET;ORAL - 120MG;EQ 15MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE
TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE
TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE
CAPSULE;ORAL - 200MG
TABLET;ORAL - 100MG;150MG
TABLET;ORAL - 133MG;200MG
TABLET;ORAL - 167MG;250MG
TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 10 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 26 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 8 Gangwal Chemicals, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 21 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 27 Controlled & Modified Release, 25 Granulation, 25 Thickeners and Stabilizers, 22 Direct Compression, 19 Disintegrants & Superdisintegrants, 17 Solubilizers, 17 Topical, 15 Lubricants & Glidants, 11 Film Formers & Plasticizers, 11 Taste Masking, 11 Parenteral, 10 Co-Processed Excipients, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

54 Fillers, Diluents & Binders
48 Coating Systems & Additives
27 Controlled & Modified Release
25 Granulation
25 Thickeners and Stabilizers
22 Direct Compression
19 Disintegrants & Superdisintegrants
17 Solubilizers
17 Topical
15 Lubricants & Glidants
11 Film Formers & Plasticizers
11 Taste Masking
11 Parenteral
10 Co-Processed Excipients
9 Empty Capsules
8 Chewable & Orodispersible Aids
6 Emulsifying Agents
5 API Stability Enhancers
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 192 News #PharmaBuzz

3 Data Compilation #PharmaFlow
2 Stock Recap #PipelineProspector
192 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions, 29 Regulatory FDF Prices, 120 Annual Reports

24 US Medicaid Prescriptions
29 Regulatory FDF Prices
120 Annual Reports

MARKET PLACE

8 APIs, 9 FDF Dossiers

8 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

96 US Patents, 9 US Exclusivities, 54 Health Canada Patents

96 US Patents
9 US Exclusivities
54 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 6 Others

4 USP
6 Others

$ API Ref.Price (USD/KG) : 314 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

120 All

01 5Atripla

02 12Biktarvy

03 1Complera

04 1Complera /Eviplera

05 8Complera/Eviplera

06 14Descovy

07 20Genvoya

08 14Odefsey

09 5Prezista/Prezcobix/Rezolsta/Symtuza

10 7Revenue share - Symtuza

11 15Stribild

12 9Symtuza

13 9Truvada

List of Suppliers

Product Main Page

01

Brand Name : Symtuza

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Pharmaconex

Not Confirmed

Brand Name : Symtuza

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 488

2019 Revenue in Millions : 379

Growth (%) : 29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Genvoya

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Pharmaconex

Not Confirmed

Brand Name : Genvoya

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 3,338

2019 Revenue in Millions : 3,931

Growth (%) : -15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Biktarvy

Pharmaconex

Not Confirmed

Brand Name : Biktarvy

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 7,259

2019 Revenue in Millions : 4,738

Growth (%) : 53

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Symtuza

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Pharmaconex

Not Confirmed

Brand Name : Symtuza

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 488

2019 Revenue in Millions : 379

Growth (%) : 29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Atripla

Pharmaconex

Not Confirmed

Brand Name : Atripla

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 349

2019 Revenue in Millions : 600

Growth (%) : -42

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Genvoya

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Pharmaconex

Not Confirmed

Brand Name : Genvoya

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 3,338

2019 Revenue in Millions : 3,931

Growth (%) : -15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Odefsey

Pharmaconex

Not Confirmed

Brand Name : Odefsey

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,672

2019 Revenue in Millions : 1,655

Growth (%) : 1

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Truvada

Pharmaconex

Not Confirmed

Brand Name : Truvada

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,448

2019 Revenue in Millions : 2,813

Growth (%) : -49

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Descovy

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Pharmaconex

Not Confirmed

Brand Name : Descovy

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,861

2019 Revenue in Millions : 1,500

Growth (%) : 24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Stribild

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Pharmaconex

Not Confirmed

Brand Name : Stribild

Pharmaconex

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 196

2019 Revenue in Millions : 369

Growth (%) : -47

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!